Eutilex Competitors and Similar CompaniesClear all
JW Therapeutics's competitors and similar companies include Neovii and ImmPACT-Bio.
 Neovii Neovii is a company specializing in polyclonal antibody immunosuppressive therapy used in organ transplantation and hematology and oncology.
|  ImmPACT-Bio ImmPACT-Bio is a company that develops a chimeric antigen receptor T-cell (CAR-T) therapy. | ||
Founding Date | Founding Date 2016 | Founding Date 2003 | Founding Date 2017 |
Type | Type Private | Type Private | Type Private |
Tags | |||
Locations | Locations CN HQ Suzhou Shi, CN | Locations Rapperswil-Jona, CH HQ Gräfelfing, DE Lexington, US | Locations Camarillo, US HQ Rishon Le Tsiyon, IL |
Employees | Employees 106 | Employees 1193% increase | Employees 845% decrease |
Funding | |||
Latest funding round | Latest funding round $ 90m (about 8 years ago) | Latest funding round N/A | Latest funding round $ 18m (almost 6 years ago) |
Total funding raised | Total funding raised $ 90m | Total funding raised N/A | Total funding raised $ 18m |
For sources of this data, please see the company profile
View Company Profiles
Neovii
HQ
Rapperswil-Jona, CH
Employees
119↑ 3% increase
Neovii is a company specializing in polyclonal antibody immunosuppressive therapy used in organ transplantation and hematology and oncology.
View companyImmPACT-Bio
HQ
Camarillo, US
Employees
84↓ 5% decrease
ImmPACT-Bio is a company that develops a chimeric antigen receptor T-cell (CAR-T) therapy.
View company